Who Buys Albendazole from India — 1411 Importers Behind a $72.5M Market

The importation of Albendazole from India involves a diverse array of buyers, each with distinct procurement behaviors and order patterns. Based on TransData Nexus data from 2022 to 2026, the top 10 buyers can be categorized as follows:

1. Government Procurement Agencies: Entities like UNICEF Supply Division (Denmark) and Ethiopian Pharmaceuticals Supply (Ethiopia) fall into this category. These organizations typically engage in large-scale, tender-based purchasing to support national health programs and disease eradication initiatives. Their procurement processes are often characterized by stringent regulatory compliance and long-term contracts to ensure consistent supply.

2. Non-Governmental Organizations (NGOs): Vitamin Angels (Netherlands) is an example of an NGO involved in the procurement of Albendazole. NGOs often purchase medications to support public health initiatives, focusing on underserved populations. Their buying behavior includes bulk purchases aligned with specific health campaigns and programs.

3. Pharmaceutical Distributors: Companies such as Hincus Pharmaceuticals (Russia), Pharma Plus Mali, S.A. (Mali), Planet Pharma (France), and Rhenus BV (Netherlands) serve as intermediaries between manufacturers and healthcare providers. They procure Albendazole in substantial quantities to distribute to hospitals, clinics, and pharmacies. Their order patterns are influenced by market demand, inventory management strategies, and regulatory requirements.

4. Scientific Bureaus: Organizations like Ibn Sina Scientific Bureau (Iraq) are involved in the importation and distribution of pharmaceuticals, including Albendazole. They often cater to both public and private healthcare sectors, ensuring the availability of essential medicines.

Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and ensuring compliance with diverse regulatory landscapes.

Import regulations for Albendazole vary across countries, necessitating a comprehensive understanding of each nation's requirements. Below is an overview for the top five importing countries:

Navigating these regulatory frameworks is essential for successful market entry and sustained operations in these countries.

The demand for Albendazole in importing countries is primarily driven by several key factors:

1. Disease Prevalence: Albendazole is widely used to treat parasitic infections such as soil-transmitted helminthiasis and lymphatic filariasis. High prevalence rates of these diseases in various regions necessitate substantial procurement of Albendazole to meet public health needs.

2. Government Healthcare Programs: Many countries have implemented national deworming programs and mass drug administration campaigns targeting parasitic infections. These initiatives often involve large-scale purchases of Albendazole to ensure widespread coverage.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased access to essential medicines, including Albendazole. This expansion ensures that vulnerable populations receive necessary treatments, thereby boosting demand.

4. WHO Essential Medicines List Procurement: Albendazole's inclusion in the World Health Organization's Essential Medicines List underscores its importance in global health. This designation encourages countries and organizations to prioritize its procurement for public health programs.

5. Tender-Based Purchasing: Government and international agencies often utilize tender-based procurement processes to acquire Albendazole. This approach ensures competitive pricing and consistent supply, facilitating large-scale distribution.

With 1,411 buyers across 150 countries, the global market for Albendazole presents significant opportunities. Understanding the interplay of disease burden, policy initiatives, and procurement mechanisms is crucial for stakeholders aiming to effectively navigate and capitalize on this market.

The importation of Albendazole from India involves a diverse array of buyers, each with distinct procurement behaviors and order patterns. Based on TransData Nexus data from 2022 to 2026, the top 10 buyers can be categorized as follows:

1. Government Procurement Agencies: Entities like UNICEF Supply Division (Denmark) and Ethiopian Pharmaceuticals Supply (Ethiopia) fall into this category. These organizations typically engage in large-scale, tender-based purchasing to support national health programs and disease eradication initiatives. Their procurement processes are often characterized by stringent regulatory compliance and long-term contracts to ensure consistent supply.

2. Non-Governmental Organizations (NGOs): Vitamin Angels (Netherlands) is an example of an NGO involved in the procurement of Albendazole. NGOs often purchase medications to support public health initiatives, focusing on underserved populations. Their buying behavior includes bulk purchases aligned with specific health campaigns and programs.

3. Pharmaceutical Distributors: Companies such as Hincus Pharmaceuticals (Russia), Pharma Plus Mali, S.A. (Mali), Planet Pharma (France), and Rhenus BV (Netherlands) serve as intermediaries between manufacturers and healthcare providers. They procure Albendazole in substantial quantities to distribute to hospitals, clinics, and pharmacies. Their order patterns are influenced by market demand, inventory management strategies, and regulatory requirements.

4. Scientific Bureaus: Organizations like Ibn Sina Scientific Bureau (Iraq) are involved in the importation and distribution of pharmaceuticals, including Albendazole. They often cater to both public and private healthcare sectors, ensuring the availability of essential medicines.

Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and ensuring compliance with diverse regulatory landscapes.

Import regulations for Albendazole vary across countries, necessitating a comprehensive understanding of each nation's requirements. Below is an overview for the top five importing countries:

Navigating these regulatory frameworks is essential for successful market entry and sustained operations in these countries.

The demand for Albendazole in importing countries is primarily driven by several key factors:

1. Disease Prevalence: Albendazole is widely used to treat parasitic infections such as soil-transmitted helminthiasis and lymphatic filariasis. High prevalence rates of these diseases in various regions necessitate substantial procurement of Albendazole to meet public health needs.

2. Government Healthcare Programs: Many countries have implemented national deworming programs and mass drug administration campaigns targeting parasitic infections. These initiatives often involve large-scale purchases of Albendazole to ensure widespread coverage.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased access to essential medicines, including Albendazole. This expansion ensures that vulnerable populations receive necessary treatments, thereby boosting demand.

4. WHO Essential Medicines List Procurement: Albendazole's inclusion in the World Health Organization's Essential Medicines List underscores its importance in global health. This designation encourages countries and organizations to prioritize its procurement for public health programs.

5. Tender-Based Purchasing: Government and international agencies often utilize tender-based procurement processes to acquire Albendazole. This approach ensures competitive pricing and consistent supply, facilitating large-scale distribution.

With 1,411 buyers across 150 countries, the global market for Albendazole presents significant opportunities. Understanding the interplay of disease burden, policy initiatives, and procurement mechanisms is crucial for stakeholders aiming to effectively navigate and capitalize on this market.